SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABTI Alpha-Beta Technology
ABTI 0.0002000.0%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (267)7/12/1997 1:18:00 PM
From: Cacaito   of 572
 
Correction: pgg-glucan comes from the wall of yeast cells (not bacteria as I said before, but bacteria shares some of this components.)

Vaccine? as describe in article I read it look like a general purpose immune stimulator regulator. It does work quite more approximate like a vaccine, stimulates receptors, generates immune response and the one's immune system takes care of the action. This is like a "primary" type of immunization. The difference is the general purpose of its actions (even against viruses, its said on the article). Definetly it is not an antibiotic that will kill by itself the germ.

Check on: clynx.com

I think the general purpose of the product is a problem, better to work with a pinpoint activity drug against or for an apecific purpose.
Well, if they failed in this trial, then they still can go to the miriad of purpouses they propose and in the long term find something that work.

In the other hand I prefer to wait, and if proven to work for current study, then there is ample time to benefit from the stock, even if I loss some of the initial flight.

One good thing it works orally, that makes the product more interesting ( for example against H. pilori that causes gastric ulcer, a billion dollar market.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News